Phase II Study with 3rd- or 4th-Line Bendamustine (Flat Dose) Therapy in Patients with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|32|8-9|488-492

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.8-9, 2009-07, pp. : 488-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Initial Experience with Temsirolimus in 2nd-, 3rd- and 4th-Line Therapy for Metastatic Renal Cell Cancer: Good Clinical Response

By  

Urologia Internationalis, Vol. 86, Iss. 3, 2011-01 ,pp. : 256-260

Karger

Access to resources Recommend Favorite

Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 305-308

Karger

Access to resources Recommend Favorite

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

Front-Line Chemotherapy with Docetaxel and Gemcitabine Administered Every Two Weeks in Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 250-256

Karger

Access to resources Recommend Favorite

First-Line Vinorelbine-Mitoxantrone Combination in Metastatic Breast Cancer Patients Relapsing after an Adjuvant Anthracycline Regimen: Results of a Phase II Study

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 384-390

Karger

Access to resources Recommend Favorite